with history

1. Presented by -
Harishankar sahu
MBA Pharmaceutical Managememt
IIHMR University Jaipur INDIA

2.  Dabur India is the 4th
Largest FMCG Company in India.
 Headquarters Dabur Tower, Ghaziabad (UP), India .
 Legacy of over 130 years .
 Strategic Business Units in
 Health care,
 Personal care and
 Food products.
 Dabur has a turnover of INR 7,800 crore with powerful brands 2014-15.
 Number of employees 6,434 (2014-15) .
 Product marketed in over 100 countries like south Asia, Africa, malasiya,
UK, Russia etc.
 Leader in Herbal Digestives with 90% market share .
 Bottom Line Driven Company.
Company
profile

3.  Established : 1884 Kolkata , Founder : Dr. S K Burman .
 Basic Motive : Manufacture of Ayurvedic Drugs .
 Added Oral Care Products in the 1970’s
 1972 Shifted base from Kolkata to New Delhi .
 1978 Launched Hajmola tablet .
 In 2004 restructured its portfolio has 5 power brands under its portfolio like
Dabur Amla, Dabur Chyawanprash, Real, Vatika and Hajmola .
 2009 - Dabur Red Toothpaste joins 'Billion Rupee Brands' club .
 2010 - Dabur Amla Hair Oils enters Limca Book of Records for achieving a
record feat of hosting the longest ever non-stop head massage marathon.
 2011 - Dabur launches its first-ever online shopping portal
www.daburuveda.com With this, Dabur is the first Indian FMCG company to
launch a dedicated online shopping portal for its beauty products range.
 2014 – Revenue 78.2 billion (US$1.2 billion) (2014-2015) .
history

4.  PERSONAL CARE SEGMENT :
 Hair Care Oil and Shampoo (VATIKA)
 Skin Care (FAIRENESS , FACE PACK)
 Oral Care (DABUR RED, GEL AND
TOOTHPASTE)
 FOODS PRODUCT RANGE:
 Juice ( REAL/ REAL ACTIV)
 Dabur Honey
 Homemade (Packaged Soups)
 AYURVEDIC HEALTH PRODUCTS:
 Digestive Segment (HAJMOLA)
 Dabur Chyawanprash
 Pudin Hara
 AYURVEDIC DRUGS
 PHARMACEUTICALS
Product
s

5. Dabur Pharma Patent Drugs & applications
• Avipathikar Tab, Dabur balm, Daburub ointment, Gastrina Tab they all are
patent products of Dabur.
• Dabur gets US patent for anti-cancer drug betulinic acid patent was granted in
April, 2001.
• Dabur Onchology has taken patent for drugs carboplatin , Paclitaxel, Epirubicin
HCL IV Between 2006-7 .
• Dabur india had been also filed more then 15 patent applications for method of
preparation of certain drugs .
AchievementsAchievements
• Dabur Vatika B&B was awarded the Grand Prix Direct Award in the Goa Fest
2015.
• Dabur ranked amongst the Top 5 Indian companies with the best Board of
Directors.
• Dabur ranked 1st in personal care and 22nd overall in the Top 50 brands by
Millward Brown.

6. Operational Data
Source- www.dabur.com FY15

7. SWOT ANALYSIS
 STRENGTHS:
 Century Old Company
 Established Brand
 Ayurvedic/ herbal Product line
 Leader in Herbal Digestives where the product has 90% of
the market share
 Innovativeness in Promotions
 WEAKNESS:
 Profitability is uneven across product line

8. SWOT ANALYSIS (contd)
 OPPORTUNITIES:
 Extend Vatika brand to new categories like Skin Care
and body wash segments
 Launch several OTC brands
 Southern India Market
 Exploring new geographical areas- local as well global
 Oral Care Segment
 Launching new Products like Hair oils, Herbal and Gel
Toothpastes etc.

9. SWOT ANALYSIS (Contd)
 THREATS:
 Competition in the FMCG sector from well established
names
 Other fields of medicine- Allopathic and Homeopathic
 Markets where Herbal products are not recognised

10.  http://www.dabur.com/About%20Dabur-Founder%20and
%20Leaders
 http://www.dabur.com/en/investors1/results/quartely/Da
bur-Q4-Results-2014-15.pdf
 www.wikipedia.com
REFERENCE